The Global Endometrial Ablation Market size is expected to reach $1.3 billion by 2024, rising at a market growth of 5.8% CAGR during the forecast period.
Endometrial ablation is used in facilitating the destruction of endometrium or thin layer of the uterine wall, and is used in treating abnormal heavy uterine bleeding. Prolonged abnormal uterine bleeding could lead to low blood count and anemia. Endometrial ablation is a technique that has gained prominence as there is no need for incisions, and the technique is very popular among women suffering menstrual problems. The factors driving the market growth are growing cases of cervical cancer, emergence of next generation ablation procedures and techniques, and growing number of hospitals and surgical centers adopting ablation procedures. However, healthcare cost-containment measures and unfavorable regulations would limit the market growth.
Global Endometrial Ablation Market Size
Based on the Technology, the Endometrial Ablation market is segmented into Radiofrequency Ablation, Cryoablation, Hydrothermal Ablation, Thermal Balloon, Hysteroscopic Ablation, and Others. Based on the end user, the market is segmented into Hospitals, Clinics, and Ambulatory Surgical Centers. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Global Endometrial Ablation Market Share
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew Plc., Olympus Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Ethicon, LLC. (Johnson & Johnson), Medtronic Plc., Hologic Corporation, Minerva Surgical, Inc., The Cooper Companies, Inc. (Cooper Surgical Inc.), AngioDynamics Inc.
Scope of the Study
Market Segmentation:
By Technology
By End User
By Geography
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 